Synthesis and some pharmacological properties of 3-(4-phenyl-5-oxo-1,2,4-triazolin-1-ylmethyl)-1,2,4-triazolin-5-thione derivatives

Acta Poloniae Pharmaceutica - Drug Research

Volumn 59, Issue 4, 2002, Pages 281-290

  Dobosz, Maria ^a   Struga, Marta ^a   Chodkowska, Anna ^a   Jagiełło Wójtowicz, Ewa ^a   Stepniak, Krystyna ^a   Kozioł, Anna E ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Pharmacological screening; Reaction of cyclization; Thiosemicarbazide derivatives; X ray structure analysis

Indexed keywords

(3,4 DIPHENYL 5 OXO 1,2,4 TRIAZOLIN 1 YLMETHYL) CARBOHYDRAZIDE; (4 PHENYL 5 OXO 1,2,4 TRIAZOLIN 1 YLMETHYL) CARBOHYDRAZIDE; 1,2,4 TRIAZOLINE 5 THIONE DERIVATIVE; HEXOBARBITAL; ISOTHIOCYANIC ACID DERIVATIVE; SODIUM HYDROXIDE; THIOSEMICARBAZIDE DERIVATIVE; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; CYCLIZATION; DEVICE; DRUG MECHANISM; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTRIC SHOCK; FEMALE; LOCOMOTION; MALE; MOTOR COORDINATION; MOUSE; NONHUMAN; PAIN PARAMETERS; SLEEP TIME; STRUCTURE ANALYSIS; TOXICITY TESTING; TRANQUILIZING ACTIVITY; X RAY ANALYSIS;

ANIMALS; MICE; MOTOR ACTIVITY; TECHNOLOGY, PHARMACEUTICAL; THIONES; TRIAZOLES;

EID: 0036629597     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Maliszewska-Guz A., Dobosz M.: Ann. Mariae Curie-Skłodowska Univ. Lublin, Sectio AA, 46/47, 5 (1991/1992).
2. Maliszewska-Guz A., Dobosz M.: Acta Polon. Pharm. 50, 219 (1993).
3. Dobosz M., Struga M.: Acta Polon. Pharm. 57, 313 (1997).
4. Dobosz M., Struga M.: Acta Polon. Pharm. 57, 123 (2000).
5. Dobosz M., Struga M., Chodkowska A., Jagiełło-Wójtowicz E.: Acta Polon. Pharm. 57, 363 (2000).
6. Dobosz M., Maliszewska-Guz A., Struga M., Kleinrok Z., Wielosz-Tokarzewska E., Jagiełło-Wójtowicz E.: Acta Polon. Pharm. 58, 35 (2001).
7. Sheldrick G.M.: SHELXS97. Program for Crystal Structure solution. University of Göttingen, Germany (1997).
8. Sheldrick G.M.: SHELXL97. Program for the Refinement of Crystal Structures. University of Göttingen, Germany (1997).
9. Litchfield J.T., Wilcoxon F.: J. Pharmacol. Exp. Ther. 96, 99 (1949).
10. Boissier J.R., Tardy J.: Deriverres J.C.: Med. Exp. (Basel) 3, 81 (1960).
11. Gross F., Tripod J., Meier R.: Schweiz Med. Wochschr. 85, 305 (1955).
12. Witkin L., Heubner G., Galdi F., O'Keefe E., Spitaletta F., Plumer A.: J. Pharmacol. Exp. Ther. 132, 400 (1951).
13. Swinyard E.A., Brown W., Goodman L.G.: J. Pharmacol. Exp. Ther. 106, 319 (1952).
14. Aron C., Simon P., Larousse C., Boissier J.R.: Neuropharmacology 10, 459 (1971).
15. Mohan J., Anjaneyulu G.S.R.: Polish J. Chem. 61, 545 (1987).
16. Wiles D.M., Suprunchuk T.: Canad. J. Chem. 46, 701 (1968).
17. Kraebel C.M., Davis S.M., London M.J.: Spectrochim. Acta 23A, 2541 (1967).